MRM Spain’s Post

When (1) your company is a stand-in for the Danish economy, (2) you've dethroned LVMH (Louis Vuitton, Moët Hennessy, and countless "Maisons" if you must know) as the biggest company in Europe, (3) your '23 operating profit has grown 40-46%, (4) the global market for obesity and anti-diabetes drugs is beyond exploding, and (5) Wegovy and Ozempic appear to be only the beginning of a wave of promising applications for semaglutide... well, then you can do whatever you want, including threaten the EU to decamp pretty much altogether in response to new rules reducing guaranteed exclusivity. #bigpharma

Thoughts on this? >> MarketingRx roundup: Cannes ad festival speakers to include Pfizer, Novo Nordisk; AZ adds TV commercial to NHL collab >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #productmarketing #pharma

💡Very often, we hear about patient centricity and collaboration between pharma companies and the ecosystem to create a greater impact. However, this is often difficult to achieve. 🙏🏻I am very proud to announce that last week we presented the Digital Therapies White Paper in which Angelini Pharma España we have participated, a clear example that this collaboration for greater impact: Consorcio DTx 🚀It hasn’t been an easy task. Two years ago, we started having conversations between different companies about the challenges surrounding digital therapies and the potential impact of advancing their regulation on patients' lives. Last week, we culminated these efforts with the presentation of this White Paper, a significant milestone for the pharma sector in Spain along with Pfizer Boehringer Ingelheim Bayer Almirall Chiesi España and many others 🙌🏻The White Paper delves into the realm of DTx, starting with an introduction that contextualizes their importance, purpose, and scope. It provides an overview of DTx regulation in countries where it already exists and underscores the necessity and future benefits of establishing appropriate regulation in Spain, including a Price and Reimbursement pathway. Additionally, the paper analyzes the challenges for DTx adoption and offers recommendations for implementation. This endeavor would have not been possible without the support of Gemma Estrada Bertran Carolina Villaró Diego Herrera Sonia Juan Pablo Sanchez Cassinello Anish Shindore Xavier Contijoch Aline Noizet Danilo Balcárcel Carmen Sánchez Cristina Conesa Marti Orlando Vergara Correa #DigitalHealth #Innovation #Healthcare #FutureOfHealth #AngeliniVoices

"It's all about organizational health, and a culture is driven by the embrace of change." Terrence Terifay, Chief Commercial Officer, Azurity Pharmaceuticals At #DPEAST 2023, Terry, Paul Murasko, Head of Digital Innovation & Marketing Operations, Azurity Pharmaceuticals and Stephanie Butler (She/Her), Senior Conference Director, Fierce Life Sciences Events, discussed with attendees how Azurity Pharmaceuticals is using a data-driven omnichannel approach in their Go-to-market strategy.🌟 Learn more about how you can get tickets to this year's Digital Pharma East September 9-12, 2024 and attend engaging discussions to keep you informed and prepared to strategically address the exciting evolution of our industry ✅: https://ow.ly/B6PK50QxZgv #DigitalPharma #DigPharm #pharmamarketing #digitalmarketing #marketing #innovationinhealthcare #FiercePharma #PharmaEvents #fiercelifesciences #WeAreFierce

Zuellig Pharma is pleased to announce that we have been appointed as the exclusive distribution partner of STADA Philippines, a fast-growing supplier of high-quality pharmaceuticals and an affiliate of Germany’s STADA Arzneimittel AG (STADA Group).   Zuellig Pharma will be the sole partner for distributing STADA’s portfolio in the Philippines, leveraging our heritage and reach as a local market leader across over 6,000 pharmacies, supermarkets, hospitals and clinics. This partnership will play a pivotal role in expanding access to STADA's flagship brands in the over-the-counter (OTC) and consumer brand categories, and to prescription medicines, particularly in ophthalmology, with more than 70 stock-keeping units (SKUs) being distributed as a start.   In particular, the partnership is expected to broaden the distribution and promotion of established consumer healthcare brands such as the FERN-C vitamin C range and the Oilatum skincare line. It will also support ophthalmic brands including Hyabak eye drops and make available to the market essential generic medicines in categories such as antibiotics and cardiovascular therapies within STADA’s portfolio.   “We are excited to partner with STADA to make quality medicines across all segments of healthcare more accessible for Filipinos across the country. As a leading healthcare solutions company, we are confident that our longstanding presence in the Philippines and our strong in-market capabilities will enable us to continue to meet the needs of the population,” said Jannette Jakosalem, Zuellig Pharma’s Managing Director for the Philippines.   Read more about the partnership here: https://lnkd.in/g_ipTQsi   #ZuelligPharmaPhilippines #Partnership #PharmaceuticalDistribution #ConsumerHealthcare #MakingHealthcareMoreAccessible

Just off the stage! Tabitha Henderson wrapped up her insightful panel discussion on "The Road to Specialty Pharmacy Network Selection" at #Asembia24. Huge thanks to her fellow panelists from Maxor Specialty Pharma, Orsini Specialty Pharmacy, and Harmony Biosciences for their invaluable observations. A few key takeaways from their panel include: - Strategic Alliances: The importance of building robust partnerships in specialty pharmacy to enhance patient access and adherence. - Innovative Solutions: Leveraging technology to streamline processes and improve patient outcomes. - Patient-Centric Approaches: Tailoring services to meet the unique needs of patients, ensuring they receive the right medication at the right time.

The Portfolio Pulse: Company features 🚀 The next company that we are highlighting is pharmi Pharmi is a company that makes pharmaceutical care more accessible. Their goal is to be the leading global digital pharmacy platform, facilitating pharmaceutical care providers in delivering the most efficient hybrid care to every medication user worldwide. To obtain this goal, they created the “MedicijnWijs” platform, providing pharmacists with a digital solution for active pharmacy care.   This platform offers pharmacists the opportunity to offer active, digital pharmacy care to medication users on a mobile platform. The platform allows pharmacists to remotely guide patients through data insights and interactions, ensuring 24/7 digital access to reliable medication information. This innovative approach not only enhances patient support but also allows the pharmaceutical care team to focus more on personalized human contact where necessary. Pharmi is part of our INZET fund. At INZET we invest in healthcare innovations that positively contribute to the quality of life of those in need of care. Pharmi is a perfect fit for INZET’s investment philosophy given its dedication to improving patient outcomes and its pursuit of becoming a global leader in the digital pharmacy space. Pharmi not only embodies the spirit of healthcare innovation but also shows a strong commitment to making pharmaceutical care more accessible. We are proud of our partnership with Pharmi and cannot wait for the impact we will achieve together! Claudia Rijcken Jeroen Londeman   #PortfolioPulse #INZET #Pharmi #Healthcare #Innovations #Healthinnovations #Digitalpharmacy #MedicijnWijs #Pharmaceuticalinnovation #Impact #Impactinvesting #Socialenterprise #Socialimpact 

We are already in #Valencia for the II National Meeting on Health Management, Financing and Accessibility to New Therapies and Medicines. #ENTYMS #therapeuticinnovation #healthcareinnovation #newtherapies #newmedicines #spain #healthcare #health #healthcareevents

2023 has been a milestone year for Everest Minds, marked by significant projects and strategic collaborations. In a series of impactful initiatives, we've served clients like the Egyptian Zakat and Charity House and Egyptian Drug Authority with advanced systems, including a comprehensive Case Management System, the Veterinary Drugs Registration System, Biological Lot Release System, and The Pharmaceutical Care Mobile App, enhancing their operational and service capacities. These projects were made possible through the support of our sponsors, Amgen, HealthforAnimals, Roche, and Abbott Egypt, whose collaboration has been crucial in driving innovation and excellence. In partnership with Roche, we've delivered key internal solutions, including the HCP eConsents, HCP Contract and Consent Electronic Generator Workflow System, and Requests Management System. Each has significantly optimized Roche's operational processes, reflecting our dedication to delivering specialized and impactful technology solutions. We extend our heartfelt gratitude to all our clients and sponsors for their trust and partnership. Your support has been instrumental in our successful journey. Looking forward to continuing our commitment to delivering innovative solutions in the coming year. Here's to further success and collaboration in 2024! #EverestMinds #Innovation #Partnership #SuccessStories #HealthcareInnovation #TechnologySolutions #OperationalExcellence #ClientSuccess #DigitalTransformation #StrategicCollaboration #TechLeadership #YearInReview